Methyldesorphine
Methyldesorphine is a semi-synthetic opioid analgesic developed in the 1940s. It is structurally related to desomorphine, a derivative of morphine. Methyldesorphine is less potent than morphine but more potent than codeine. It has been used in the treatment of severe pain, often for post-operative pain management.
Chemistry[edit]
Methyldesorphine, also known as 3-methyl-6-desoxy-7,8-dihydro-6-desoxymorphine, is a semi-synthetic opioid derived from morphine. It is a member of the phenanthrene group of opioids, which also includes morphine, codeine, and desomorphine. The chemical structure of methyldesorphine is similar to that of morphine, with the addition of a methyl group at the 3 position.
Pharmacology[edit]
Methyldesorphine acts primarily as an agonist at the mu-opioid receptor, the main site of action for the most commonly used opioids. It has a high affinity for this receptor, which is responsible for its analgesic effects. Methyldesorphine also has a lower affinity for the kappa-opioid receptor and the delta-opioid receptor, which may contribute to its analgesic and sedative effects.
Clinical Use[edit]
Methyldesorphine has been used in the treatment of severe pain, often for post-operative pain management. It is typically administered via injection. Due to its potency and potential for addiction, it is classified as a Schedule II controlled substance in the United States.
Side Effects[edit]
Like other opioids, methyldesorphine can cause a range of side effects, including nausea, vomiting, constipation, and respiratory depression. It can also cause physical dependence and addiction with long-term use.
See Also[edit]
-
Methyldesorphine
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian